ID: MRFR/MED/0520-CR | 78 Pages | Published By Rahul Gotadki on September 2019
The Spectral Computed Tomography (CT) Market is anticipated to reach USD 7822.35 Million by 2030 at 1.38% CAGR during the forecast period 2022-2030. Spectral computed tomography is also known as dual-energy CT which is techniques that are used two individual x-ray photon energy spectra and allows the interrogation of materials which has different attenuation properties at different energies in another word it is basically an advanced medical imagining device which is helpful in differentiating and characterizing tissues with the help of the high quality of x-ray images.
Spectral Computed Tomography has two different energy spectra which concisely produce material density-based images of spectral computed tomography. The major factor that is responsible for the growth of the Spectral Computed Tomography (CT) market is the increasing prevalence of diseases including neurological disorders, cancer, and cardiac diseases around the world. The rising expenditure in the IT sector on healthcare and the advancement in the technology of diagnostics sectors are some other major factors for the market growth.
This report contains all the information on the Spectral Computed Tomography market research and the market strengths. The report also contains the culmination of dynamics, segmentation, key players, regional analysis, and other important factors. And a detailed analysis of the Spectral Computed Tomography (CT) market analysis and forecast to 2025 is also included in the report.
Covid 19 Analysis
The rising cases of covid 19 across the globe have raised the demand for CT scanners which is likely to out positive impact on the Spectral Computed Tomography table. According to the reports, the Abu Dhabi Health Services Company (SEHA) has introduced a mobile CT scanner in the United Arab Emirates in order to detect pneumonia in patients of covid 19. This is proof that hospitals are taking the help of the CT scanner to detect covid 19.
The increased chronic diseases, the rising geriatric population across the globe, the advancement in the technological field, and the preferences of image-guided interventions in the medical field are the major driving factor for the growth of the spectral computed tomography (CT) market.
The rising adaptation of IT in the medical field in order to improve the product quality is a major step in the spectral computed tomography (CT) market. It is creating major opportunities in the health care sector as it plays an important role in the medical devices industries by enhancing product efficiency at every level of use. Medical image management is directly linked with diagnosis services and it is an important part of the healthcare IT sector.
The high cost involved in spectral computed tomography is likely to create a hurdle in the growth of the spectral computed tomography (CT) market. The easy availability of imaging methods in the market is projected to hamper the spectral computed tomography (CT) market growth.
The availability of alternative imaging methods in the spectral computed tomography (CT) market is projected to create major challenges for the key manufacturers in the market.
Cumulative Growth Analysis
According to the reports, the spending on the healthcare it sector has been increasing rapidly from the past few years which is predicted to boost the spectral computed tomography (CT) market and the related services as well during the forecast period of 2019 to 2025. The approval and acceptance of cloud technology in medical image devices offer easy sharing of data and storage, it also raises the acquisitions and mergers between IT companies and healthcare which ultimately accelerates the growth of the spectral computed tomography market. The adoption of cloud technology in medical imaging in the developed countries like Japan, the UK, and the US are contributing to the market growth.
Value Chain Analysis
According to the reports, the spectral computed tomography market is segmented on the basis of application, end-users, and regions. On the basis of application, the Spectral Computed Tomography (CT) market has been segmented into oncology, gastrointestinal diseases, cardiology, and musculoskeletal disorders. Oncology segments are predicted to witness the maximum Spectral Computed Tomography (CT) market share during the forecast period. On the basis of end-users, the Spectral Computed Tomography market has been segmented into diagnostic centers, and hospitals & clinics.
The market is segmented on the basis of the application, end-users, and regions. The spectral computed tomography market is expected to witness decent growth during the forecast period.
Based on the application, the market is segmented into oncology, gastrointestinal diseases, cardiology, and musculoskeletal disorders.
Based on the propulsion types, the market is segmented into diagnostic centers, and hospitals & clinics.
According to the reports, on the basis of regions the spectral computed tomography (CT) market has based segmented into the Americas, Europe, Asia Pacific, and Middle East & Africa. The Asia Pacific segment is predicted to hold the largest Spectral Computed Tomography market share due to the rising prevalence of cancer, carnivorous diseases, and also due to the rising geriatric population with several diseases. America is predicted to hold the second-largest spectral computed tomography (CT) market share during the forecast period due to the presence of several medical device companies, innovation in devices to enhance the quality of life, and easing expenditure on healthcare.
The European region holds the third-largest spectral computed tomography market share due to the increasing numbers of medical device industries, rise in per capita income of individuals, the more spending by consumers n healthcare, and the presence of developed countries in these regions are the major factor for the growth of the spectral computed tomography (CT) market in this region.
The prominent key players of the Spectral Computed Tomography market are focused on making strategies to increase the demand for Spectral Computed Tomography (CT). The innovation, developments in products, and mergers & acquisitions are the key strategies of these prominent players in the Spectral Computed Tomography market.
Major Key Players
The following report comprises of –
Spectral Computed Tomography Market, by Application
Spectral Computed Tomography Market, by End User
Spectral Computed Tomography Market, by Region
|Market Size||USD 7822.35 Million|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Application and End User|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||General Electric Company (US), Koninklijke Philips N.V. (Amsterdam, Netherlands), MARS Bioimaging Ltd (Christchurch, New Zealand), Neusoft Corporation (China), Shenzhen Anke High-tech Co., Ltd (China), Siemens (UK), and PerkinElmer Inc. (Waltham, Massachusetts)|
|Key Market Opportunities||The increasing acceptance and approval of the cloud technology in medical image devices provide easy storage and sharing of huge data|
|Key Market Drivers||
spectral CT market is expected to reach USD 7822.35 Million by 2030.
The global market is expected to exhibit a strong 1.38% CAGR over the forecast period till 2030.
The rise in demand for advanced medical imagining modalities is the major driver for the market.
Asia pacific holds the largest share in the global Spectral Computed Tomography (CT) market followed by America, Europe, and Middle East & Africa.
Leading players in the market include MARS Bioimaging, GE, and Koninklijke Philips, among others.